LuSeed Vascular

LuSeed Vascular is an innovative medical technology startup dedicated to transforming the landscape of neurovascular disease treatment. At the heart of its offering is the LuSeed DOME™, a groundbreaking device engineered to address the complex challenges associated with both bifurcation and sidewall brain aneurysms. The device’s unique braided mesh design allows for intuitive, rapid, and precise delivery into the aneurysm, regardless of the catheter tip’s location or angle of entry. This agnostic approach simplifies procedures for neurointerventional physicians and reduces the risk of complications, making advanced aneurysm care more accessible across varying levels of clinical expertise.

One of the most significant advantages of the LuSeed DOME™ is its ability to minimize protrusion into parent arteries, which eliminates the chronic need for high-risk dual antiplatelet therapy. This innovation not only enhances patient safety, especially in ruptured cases, but also streamlines post-procedure care and reduces the operational burden on hospitals. The device’s design supports quick implantation, often within minutes, thus optimizing cath-lab utilization and improving overall hospital efficiency.

LuSeed Vascular’s leadership team brings extensive experience in medical device development, regulatory strategy, and clinical affairs, ensuring that its solutions are rigorously tested and aligned with global healthcare standards. By focusing on the intersection of engineering excellence and clinical impact, the company is setting a new standard for neurovascular intervention. Through its commitment to advancing medical technology, LuSeed Vascular is poised to make a lasting contribution to patient outcomes and the broader field of health tech